COMMUNIQUÉS West-GlobeNewswire
-
Vistin Pharma ASA : Delivers 22% revenue growth in first quarter 2018
26/04/2018 - 07:02 -
MDxHealth Announces Positive Clinical Updates for ConfirmMDx
26/04/2018 - 07:01 -
MDxHealth annonce des mises à jour cliniques positives pour ConfirmMDx
26/04/2018 - 07:01 -
Biocartis Group NV: BIOCARTIS Q1 2018 BUSINESS UPDATE
26/04/2018 - 07:01 -
Zealand announces successful End-of-Phase 2 meeting with FDA on glepaglutide for short bowel syndrome
26/04/2018 - 06:51 -
Medibio Announces Scientific Advisory Board
26/04/2018 - 06:00 -
Western Canadian Cannabis Use: Proprietary Study Indicates Half of Western Canadians Are Cannabis Users, Lapsed Users, or Interested in Trying Cannabis
26/04/2018 - 02:09 -
Eloxx Pharmaceuticals Announces Uplisting to Nasdaq and Pricing of $50 Million Public Offering of Common Stock
26/04/2018 - 00:22 -
Nextech to Showcase Enhanced Cloud-Based Technology at The Aesthetic Meeting 2018
25/04/2018 - 23:39 -
Dentsply Sirona Declares Quarterly Cash Dividend
25/04/2018 - 23:15 -
Paratek Pharmaceuticals to Report First Quarter 2018 Financial Results on May 9, 2018
25/04/2018 - 23:03 -
Progenics Pharmaceuticals Announces Presentations at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
25/04/2018 - 23:00 -
R1 RCM to Release First Quarter 2018 Results on May 9
25/04/2018 - 23:00 -
Dentsply Sirona to Host First Quarter 2018 Conference Call on May 7th
25/04/2018 - 23:00 -
Osiris Announces New Peer-Reviewed Publication Summarizing Clinical Outcomes of Viable Cryopreserved Placental Membranes for Management of Chronic Diabetic Foot Ulcers in Real World Setting
25/04/2018 - 22:30 -
BeyondSpring to Present Neutropenia Clinical Trial Data on Lead Asset, Plinabulin, at 2018 ASCO Annual Meeting
25/04/2018 - 22:30 -
FDA Determines that Afrezza REMS Communication Plan Has Met Goals and REMS No Longer Necessary
25/04/2018 - 22:30 -
Dyadic International to Announce First Quarter 2018 Financial Results and Host Conference Call on Thursday May 10, 2018
25/04/2018 - 22:30 -
Vital Therapies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
25/04/2018 - 22:30
Pages